Mdig promotes oncogenic gene expression through antagonizing repressive histone methylation markers
Conclusion: Taken together, our study provides the first insight into the molecular effects of mdig as an antagonist for repressive histone methylation markers and suggests that targeting mdig may represent a new area to explore in cancer therapy.
Source: Theranostics - Category: Molecular Biology Authors: Qian Zhang, Chitra Thakur, Yao Fu, Zhuoyue Bi, Priya Wadgaonkar, Liping Xu, Zhipeng Liu, Wanqing Liu, Jian Wang, Benjamin L. Kidder, Fei Chen Tags: Research Paper Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Epithelial Cancer | Genetics | Molecular Biology | Study